EU Blesses Merck's $41B Schering-Plough Deal
EU antitrust regulators have cleared Merck & Co.'s proposed $41.1 billion acquisition of Schering-Plough Corp., a move that will make it the second-largest prescription drug company in the world....To view the full article, register now.
Already a subscriber? Click here to view full article